Vernet M
Hôpital de la Croix-Rousse, Laboratoire de Biochimie, 103, Grande-Rue de la Croix-Rousse, 69317 Lyon cedex 4.
Ann Biol Clin (Paris). 1999 Jan-Feb;57(1):9-18.
Transferrin receptor is a key protein for the cellular uptake of transferrin iron. The highest number of transferrin receptors is on the surface of erythroblasts. The released iron is used for hemoglobinosynthesis. Regulation occurs at mRNA level depending on the intracellular iron concentration. The synthesis of ferritin and transferrin receptor are regulated in an opposite manner. Serum transferrin receptor is a truncated monomeric form of the cellular receptor. Most of the circulating receptors come from erythroid marrow precursors. Its level mirrors the total tissue receptor mass, it depends on the rate of erythropoiesis and on the iron status. Serum transferrin receptor is easily measured by Elisa methods but the lack of standardization triggers large differences in the results. Unlike ferritin, the concentration of serum transferrin receptors is unaffected in inflammatory diseases, infections, malignancies or cytolysis. In these conditions its measurement is particularly valuable for assessing an associated iron deficiency. It is a very useful tool for the diagnosis of different causes of anemia. In chronic renal failure serum transferrin receptor can predict whether patients will respond to rHu EPO therapy.
转铁蛋白受体是细胞摄取转铁蛋白铁的关键蛋白。成红细胞表面的转铁蛋白受体数量最多。释放出的铁用于血红蛋白合成。调节作用发生在mRNA水平,取决于细胞内铁浓度。铁蛋白和转铁蛋白受体的合成以相反的方式受到调节。血清转铁蛋白受体是细胞受体的截短单体形式。大多数循环受体来自红系骨髓前体细胞。其水平反映了组织中受体的总量,它取决于红细胞生成速率和铁状态。血清转铁蛋白受体可通过酶联免疫吸附测定(ELISA)方法轻松检测,但缺乏标准化导致结果差异很大。与铁蛋白不同,血清转铁蛋白受体的浓度在炎症性疾病、感染、恶性肿瘤或细胞溶解时不受影响。在这些情况下,其检测对于评估相关的缺铁情况特别有价值。它是诊断不同类型贫血原因的非常有用的工具。在慢性肾衰竭中,血清转铁蛋白受体可以预测患者是否会对重组人促红细胞生成素(rHu EPO)治疗产生反应。